N-methyl-6-[4-[(2-morpholin-4-yl-4-pyridinyl)methoxy]phenyl]-2-pyridin-3-ylquinazolin-4-amine
C30H28N6O2 — CID 71181254
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-methyl-6-[4-[(2-morpholin-4-yl-4-pyridinyl)methoxy]phenyl]-2-pyridin-3-ylquinazolin-4-amine
N-methyl-6-[4-[(2-morpholin-4-yl-4-pyridinyl)methoxy]phenyl]-2-pyridin-3-ylquinazolin-4-amine (PubChem CID 71181254) has the molecular formula C30H28N6O2 and a molecular weight of 504.59 g/mol. Its IUPAC name is N-methyl-6-[4-[(2-morpholin-4-yl-4-pyridinyl)methoxy]phenyl]-2-pyridin-3-ylquinazolin-4-amine.
Molecular Properties
| Compound Name | N-methyl-6-[4-[(2-morpholin-4-yl-4-pyridinyl)methoxy]phenyl]-2-pyridin-3-ylquinazolin-4-amine |
|---|---|
| PubChem CID | 71181254 |
| Molecular Formula | C30H28N6O2 |
| Molecular Weight | 504.59 g/mol |
| Exact Mass | 504.23 |
| IUPAC Name | N-methyl-6-[4-[(2-morpholin-4-yl-4-pyridinyl)methoxy]phenyl]-2-pyridin-3-ylquinazolin-4-amine |
| SMILES | CNc1nc(-c2cccnc2)nc2ccc(-c3ccc(OCc4ccnc(N5CCOCC5)c4)cc3)cc12 |
| InChI | InChI=1S/C30H28N6O2/c1-31-30-26-18-23(6-9-27(26)34-29(35-30)24-3-2-11-32-19-24)22-4-7-25(8-5-22)38-20-21-10-12-33-28(17-21)36-13-15-37-16-14-36/h2-12,17-19H,13-16,20H2,1H3,(H,31,34,35) |
| InChIKey | UFSVSPQSZJOLOM-UHFFFAOYSA-N |
| XLogP | 5.21 |
| TPSA | 85.29 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 38 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 504.59 |
| LogP ≤ 5 | 5.21 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 71181254 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.